COMMUNIQUÉS West-GlobeNewswire

Medicana Health Group Conducts Pre-World Cup Health Checks for the Türkiye National Football Team
18/06/2026
As the healthcare sponsor of Türkiye’s National Teams since 2024, Medicana Health Group carried out detailed medical screenings for national football players ahead of their World Cup journey to the United States Photo: [...]
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
18/06/2026
VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc., a Vancouver-based biopharmaceutical company focused on skin health and longevity, today announced positive preclinical [...]
PracticeLink Announces Spring 2026 First Practice Fund Scholarship Recipients
18/06/2026
Nine future healthcare providers awarded scholarships to support their transition into practice ST. LOUIS and HINTON, West Virginia, June 18, 2026 (GLOBE NEWSWIRE) -- PracticeLink , the nation’s most trusted physician [...]
Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026
18/06/2026
-- Presentations highlight new clinical, real-world, and patient-centered insights on metreleptin across lipodystrophy populations -- BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business [...]
NMDP Teams Up with Boozer Brothers to Help More Patients Access Blood Stem Cell Transplants
18/06/2026
The brothers urge young adults to join the NMDP Registry and help save lives by supporting patient access to blood stem cell transplants MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- NMDP, a global nonprofit leader in [...]
SK pharmteco annonce une collaboration stratégique avec Orphan Therapeutics Accelerator pour le développement et la fabrication de produits thérapeutiques visant les maladies rares
18/06/2026
RANCHO CORDOVA, Californie, 18 juin 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour un accord de collaboration avec Orphan Therapeutics Accelerator (OTXL), une organisation à but non lucratif spécialisée dans les [...]
COUR Pharma Announces Closing of $50 Million Series B
18/06/2026
Round led by Lumira Ventures and Roche Venture Fund with new investment from Sanofi CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ﬁrst-in-class, antigen- [...]
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
18/06/2026
Designation highlights significant regulatory milestone and provides a potential pathway to seven years of U.S. market exclusivity LA JOLLA, CA, June 18, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” [...]
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18/06/2026
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases Denali was awarded Priority Review Voucher [...]
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
18/06/2026
Principal Investigator Kathleen N. Moore, M.D., a leading expert in advanced ovarian cancer, will present the poster TARPON SPRINGS, Fla., June 18, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ( [...]
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide
18/06/2026
Broader pharmacy access, channel expansion, and payer coverage position Arbli ™ for increased prescription volume and revenue growth COMMACK, NY, June 18, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX [...]
Silo Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
18/06/2026
SARASOTA, FLA., June 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
18/06/2026
Accomplished commercial aesthetics veteran to drive sales channel expansion and pipeline development MELVILLE, N.Y., June 18, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative,” “BRTX,” or the “ [...]
COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO
18/06/2026
TORONTO, ONTARIO, June 18, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) announced the results from its annual general and special meeting of shareholders [...]
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
18/06/2026
Company to Loan $6.5 Million Prior to Closing to Fund Order Backlog and Working Capital Needs – Combined Company to be Renamed NOMAD Power Solutions, Inc. and Trade Under a New Ticker Symbol BOCA RATON, Fla. & [...]
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
18/06/2026
Georgia’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center; well recognized at the forefront of cancer innovation and discovery nationwide CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- MAIA [...]
FDA Approves First Single-Dose Generic Treatment for Influenza
18/06/2026
Drug increases ease of use for patients, in advance of flu season Silver Spring, MD, June 18, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir [...]
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
18/06/2026
First U.K. case series demonstrates successful use of RECELL GO ® in 17 burn and reconstructive surgery patients Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in [...]
International Myeloma Foundation’s Black Swan Research Initiative Presents Data and Results of Phase 2 ASCENT Cure Trial at EHA 2026 Congress
18/06/2026
Quadruplet Dara-KRd combination demonstrates high rates of response in high-risk smoldering myeloma patients similar to that observed in NDMM; MRD negativity maintained in nearly two-thirds of patients, with median [...]

Pages